• Information for Healthcare Professionals Home
• Drug Information
• Safety Information
• Clinical Trials, Research Tools
• Continuing Education

• FDA Acronyms and Abbreviations
• A - Z Index
• Contact Us

October 9. FDA issues statement following CHPA's announcement on nonprescription over-the-counter cough and cold medicines in children FDA Statement

September 18. FDA releases its fourth issue of the FDA Drug Safety Newsletter.

September 18. Covidien and Mallinckrodt Inc. inform healthcare professionals of important new safety information in prescribing Phosphocol P 32. MedWatch Safety Information

September 16. FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India. Drug Information

September 12. Genentech informs healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML). MedWatch Safety Information

Previous News Items

• FDA Online Tutorial: An Introduction to the Improved FDA Prescription Drug Labeling
• Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book)
• HIV and AIDS - index to information on HIV/AIDS treatment and therapies
• New Requirements for Prescribing Information
• National Drug Code Directory - current list of all drugs manufactured, prepared, propagated, compounded, or processed for commercial distribution
• Drug Preparedness and Response to Bioterrorism

Search for Brand Name and Generic Drugs
current and archival drug labels, drug approval histories, and more

find a generic equivalent to a drug

report adverse events or product problems

sign up for FDA updates

find career opportunities at FDA